|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 135.60 SEK | +2.11% |
|
-4.64% | +5.77% |
| 06-12 | Handelsbanken Fonder increases stake in Alligo to just over 5 percent | FW |
| 06-08 | Espiria Sweden Small Cap rose 6.1 percent in May - Hansa Biopharma contributed positively | FW |
Company Valuation: Alligo AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 9,692 | 4,003 | 6,206 | 6,168 | 6,421 | 6,792 | - | - |
| Change | - | -58.7% | 55.04% | -0.61% | 4.1% | 5.77% | - | - |
| Enterprise Value (EV) 1 | 11,964 | 4,003 | 8,846 | 9,071 | 9,564 | 9,475 | 9,103 | 8,718 |
| Change | - | -66.54% | 120.98% | 2.54% | 5.43% | -0.93% | -3.92% | -4.23% |
| P/E Ratio | 22.6x | 0.99x | 12.7x | 22.5x | 24.6x | 14.3x | 11.5x | 9.96x |
| PBR | 2.83x | - | 1.75x | 1.69x | 1.71x | 1.63x | 1.49x | 1.35x |
| PEG | - | 0x | -0.1x | -0.5x | -5.18x | 0.2x | 0.5x | 0.7x |
| Capitalization / Revenue | 1.14x | 0.43x | 0.66x | 0.65x | 0.67x | 0.67x | 0.63x | 0.6x |
| EV / Revenue | 1.41x | 0.43x | 0.93x | 0.96x | 0.99x | 0.93x | 0.85x | 0.77x |
| EV / EBITDA | 9.9x | 3.47x | 6.91x | 7.92x | 8.81x | 6.99x | 5.95x | 5.26x |
| EV / EBIT | 28x | 5.98x | 11.8x | 18x | 20.3x | 13.3x | 10.6x | 9x |
| EV / FCF | 15.5x | - | 11.4x | 10.8x | 13.8x | 9.12x | 8.72x | 7.82x |
| FCF Yield | 6.45% | - | 8.79% | 9.27% | 7.27% | 11% | 11.5% | 12.8% |
| Dividend per Share 2 | 1.75 | - | 3.5 | 2 | 2.2 | 3.62 | 4.332 | 5.068 |
| Rate of return | 0.91% | - | 2.82% | 1.62% | 1.72% | 2.67% | 3.2% | 3.74% |
| EPS 2 | 8.48 | 80.44 | 9.76 | 5.47 | 5.21 | 9.478 | 11.83 | 13.62 |
| Distribution rate | 20.6% | - | 35.9% | 36.6% | 42.2% | 38.2% | 36.6% | 37.2% |
| Net sales 1 | 8,508 | 9,333 | 9,462 | 9,442 | 9,638 | 10,183 | 10,761 | 11,280 |
| EBITDA 1 | 1,208 | 1,155 | 1,281 | 1,146 | 1,085 | 1,356 | 1,530 | 1,657 |
| EBIT 1 | 427 | 669 | 748 | 505 | 471 | 714.5 | 858.5 | 968.5 |
| Net income 1 | 429 | 4,061 | 497 | 274 | 261 | 476.8 | 592.8 | 682.2 |
| Net Debt 1 | 2,272 | - | 2,640 | 2,903 | 3,143 | 2,683 | 2,312 | 1,926 |
| Reference price 2 | 192.00 | 79.30 | 124.00 | 123.20 | 128.20 | 135.60 | 135.60 | 135.60 |
| Nbr of stocks (in thousands) | 50,481 | 50,481 | 50,051 | 50,068 | 50,088 | 50,088 | - | - |
| Announcement Date | 15/02/22 | 16/02/23 | 16/02/24 | 14/02/25 | 13/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E Ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 14.01x | 0.92x | 6.89x | 2.73% | 697M | ||
| 28.86x | 3.27x | 19.01x | 0.73% | 62.04B | ||
| 37.43x | 5.83x | 25.68x | 1.99% | 53.26B | ||
| 33.49x | 5.29x | 19.68x | 0.95% | 12.26B | ||
| 29.8x | 2.37x | 19.24x | 0.6% | 11.79B | ||
| 18.49x | 1.42x | 11.48x | -.--% | 9.37B | ||
| 27.6x | 1.76x | 15.41x | 3.03% | 6.45B | ||
| 16.32x | 1.06x | 9.32x | 3.91% | 3.79B | ||
| 26.83x | - | - | - | 2.6B | ||
| 143.79x | 0.55x | 12.41x | - | 2.49B | ||
| Average | 37.66x | 2.50x | 15.46x | 1.74% | 16.47B | |
| Weighted average by Cap. | 32.76x | 3.93x | 20.31x | 1.29% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ALLIGO B Stock
- Valuation Alligo AB
Select your edition
All financial news and data tailored to specific country editions
















